| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3968148 | Obstetrics and Gynecology Clinics of North America | 2007 | 20 Pages |
Abstract
The purpose of this review is to provide a brief overview for understanding the management guidelines of gestational diabetes. The rationale for the use of oral antidiabetic drugs is provided based on validation by appropriately conducted research trials. Concerns over teratogenicity due to possible placental transfer, neonatal and maternal outcome, and basic pharmacologic benefits are addressed.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Oded MD, PhD,